REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Fmc - Dialyzacne Sluzby, S.R.O. (Slovakia)

Main Activities: Ambulatory Health Care Services
Full name: Fmc - Dialyzacne Sluzby, S.R.O. Profile Updated: July 31, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Fmc - Dialyzacne Sluzby, S.R.O. is an enterprise in Slovakia, with the main office in Bratislava. It operates in the Ambulatory Health Care Services industry. Fmc - Dialyzacne Sluzby, S.R.O. was incorporated on October 22, 2001. Fmc - Dialyzacne Sluzby, S.R.O. currently employs 500 - 999 (2025) people. The latest financial highlights indicate a net sales revenue drop of 4.85% in 2025. Its’ total assets recorded a negative growth of 8.63%. Fmc - Dialyzacne Sluzby, S.R.O.’s net profit margin decreased by 0.08% in 2025.

Headquarters
Plynarenska, 7/C
Bratislava; Bratislavsky; Postal Code: 82109

Contact Details: Purchase the Fmc - Dialyzacne Sluzby, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Fmc - Dialyzacne Sluzby, S.R.O. report to view the information.
Registered Capital:
Purchase the Fmc - Dialyzacne Sluzby, S.R.O. report to view the information.
Financial Auditors:
Purchase the Fmc - Dialyzacne Sluzby, S.R.O. report to view the information.
Incorporation Date:
October 22, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
94.8%
Purchase this report to view the information.
5.2%
Company Performance
Financial values in the chart are available after Fmc - Dialyzacne Sluzby, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-4.85%▼
Total Operating Revenue
-4.24%▼
Operating Profit
76.86%▲
EBITDA
6.7%▲
Net Profit/Loss for the Period
-7.83%▼
Total Assets
-8.63%▼
Total Equity
-2.41%▼
Operating Profit Margin
0.92%▲
Net Profit Margin
-0.08%▼
Return on Equity (ROE)
-0.23%▼
Debt / Equity
0%
Quick Ratio
0.43%▲

Similar companies

Unilabs Slovensko, S. R. O.
 
Medirex, A.S.
Slovenske Liecebne Kupele Piestany, A.S.
 
Procare, A.S.
Slovenske Liecebne Kupele Rajecke Teplice, A.S.
 
Kupele Trencianske Teplice, A.S.
B. Braun Avitum S.R.O.
 
Klinicka Biochemia S.R.O.
Kardiocentrum Nitra S.R.O.
 
Bardejovske Kupele A. S.

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo